Page last updated: 2024-09-03

phosphocyclocreatine and Neoplasms

phosphocyclocreatine has been researched along with Neoplasms in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Hamlin, HA; Kaddurah-Daouk, R; Lillie, JW; O'Keefe, M; Valinski, H; Varban, ML1

Other Studies

1 other study(ies) available for phosphocyclocreatine and Neoplasms

ArticleYear
Cyclocreatine (1-carboxymethyl-2-iminoimidazolidine) inhibits growth of a broad spectrum of cancer cells derived from solid tumors.
    Cancer research, 1993, Jul-01, Volume: 53, Issue:13

    Topics: Animals; Antineoplastic Agents; Cell Division; Cell Line; Cell Transformation, Neoplastic; Creatine Kinase; Creatinine; Female; Humans; Imidazolidines; Isoenzymes; Male; Mice; Mice, Nude; Neoplasms; Neoplasms, Experimental; Phosphocreatine; Transplantation, Heterologous; Tumor Cells, Cultured; Uterine Cervical Neoplasms

1993